MYNAMynaric AG

Nasdaq mynaric.com


$ 5.44 $ -0.01 (-0.19 %)    

Monday, 06-May-2024 13:14:17 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 5.21
$ 4.90
$ 0.00 x 0
$ 0.00 x 0
$ 4.90 - $ 5.48
$ 3.01 - $ 7.58
3,194
na
29.53M
$ 1.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 reported-saturday-mynaric-ag-launches-volume-production-and-dispatches-first-condor-mk3-optical-head

Mynaric AG (NASDAQ:MYNA)(ISIN: US62857X1019)(FRA:M0YN)(ISIN: DE000A31C305) (the "Company") today, following customer ap...

 mynaric-selected-for-phase-2-of-darpa-space-based-adaptive-communications-node-program

DARPA's Space-BACN program envisions a low-cost, scalable optical communications terminal that could be reconfigured to wor...

 why-despegarcom-shares-are-trading-higher-by-over-16-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial ...

 why-reshape-lifesciences-shares-are-trading-higher-by-around-45-here-are-20-stocks-moving-premarket

Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA P...

Core News & Articles

Mynaric (NASDAQ:MYNA)(FRA:M0YN) has today entered into a definitive agreement with Northrop Grumman for the delivery of optical...

 mynaric-bags-another-contract-worth-30m-with-a-us-customer-for-its-condor-mk3-terminals

Mynaric (NASDAQ:MYNA)(FRA:M0YN) has today entered into a definitive agreement for an additional order from an existing undisclo...

 mynaric-now-expects-fy23-ifrs-15-revenue-to-remain-around-the-same-level-as-2022-revenue-of-44m-compared-to-previous-guidance-of-a-significant-increase

Mynaric (NASDAQ:MYNA)(FRA:M0YN) has today announced an update to full-year 2023 guidance for its key financial performance metr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION